Quhuo Limited, through its subsidiaries, operates a workforce operational solution platform in the People's Republic of China. The company provides tech-enabled and end-to-end operational solutions to blue-chip on-demand consumer service businesses in industries with e-commerce exposure, including delivery, ride-hailing, housekeeping, and bike-sharing. It also offers on-demand delivery solutions for industry customers with focus on items, such as grocery, and prepared and fresh food; ride hailing solutions for ride-hailing companies; housekeeping solutions and other services for short-term rental properties and hotel cleaning services; and shared-bike maintenance solutions to address the demand for maintenance and distribution services from bike-sharing companies. In addition, the company develops computer software and applications. Quhuo Limited was founded in 2012 and is based in Beijing, the People's Republic of China.

Quhuo Limited

Golden Matrix Group, Inc. provides enterprise software-as-a-service solutions for online casino and sports betting operators. The company develops and owns online gaming intellectual property; and builds gaming platforms for customers located primarily in the Asia Pacific region and Europe. Its platform facilitates gaming customers in operating online casinos, sportsbooks, lottery, and live games; and provides customers with access to a portfolio of licensed gaming content, which are provided by gaming content providers. The company also provides services and resells third party gaming content to licensed online gaming distributors. Its platform is accessed through desktop and mobile applications. The company was formerly known as Source Gold Corp. and changed its name to Golden Matrix Group, Inc. in April 2016. Golden Matrix Group, Inc. was incorporated in 2008 and is based in Las Vegas, Nevada.

Golden Matrix Group, Inc.

Lavoro Limited operates as an agricultural inputs retailer. It sells agricultural inputs, including seeds, fertilizers and specialty products, crop protection products, and others for the agricultural industry. The company also produces specialty fertilizers, crop protection products, and biological crop inputs. It operates in Brazil, Colombia, and Uruguay. The company sells its products through its physical stores and digital. Lavoro Limited was founded in 2017 and is based in Sao Paulo, Brazil.

Lavoro Limited

T3 Defense Inc. operates as a holding company that focuses on acquiring and operating defense businesses. The company offers artificial intelligence (AI) for defense, 3D mapping and surveillance, and UAVs. The company was formerly known as Nukkleus Inc. and changed its name to T3 Defense Inc. in February 2026. The company was founded in 2013 and is based in New York, New York.

T3 Defense Inc.

Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria, an agricultural company, engages in the production of agricultural commodities in Brazil and other Latin American countries. The company operates through Agricultural Business, and Business Urban Properties and Investments segments. It is also involved in the management, development, and ownership of shopping malls, office buildings, and hotels; sale of grain derivatives, such as flour and oil; production and sale of crops, such as soybean, sugarcane, wheat, corn, oilseed, and sunflower, as well as sorghum and peanuts; and breeding, purchasing, and/or fattening of cattle for sale to slaughterhouses and supermarkets. In addition, it leases its farms to third parties for agriculture, cattle breeding, and seed production; and offers agricultural services. The company was incorporated in 1936 and is headquartered in Buenos Aires, Argentina.

Cresud S.A. Warrant 2021-08.03.26 on Cresud

New Fortress Energy Inc. operates as an integrated gas-to-power infrastructure company that provides energy and development services to end-users worldwide. The company operates in two segments, Terminals and Infrastructure, and Ships. The Terminals and Infrastructure segment engages in the natural gas procurement and liquefaction; and shipping, logistics, facilities and conversion, or development of natural gas-fired power generation. The Ships segment offers floating storage and regasification units, and liquefied natural gas (LNG) carriers which are leased to customers under long-term or spot arrangements. The company operates LNG storage and regasification facility at the Port of Montego Bay, Jamaica; marine LNG storage and regasification facility in Old Harbour, Jamaica; landed micro-fuel handling facility in San Juan, Puerto Rico; marine LNG storage and regasification facility in Sergipe, Brazil; and LNG receiving facility in La Paz, Mexico, as well as Miami facility. New Fortress Energy Inc. was founded in 1998 and is based in New York, New York.

New Fortress Energy Inc.

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.

Agilon Health, Inc.

Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company is based in Warren, New Jersey.

Tevogen Bio Holdings Inc.

Webull Corporation operates as a digital investment platform. The company offers trading services, wealth management product distribution, market data and information, user community, and investor education.​

Webull Corporation Class A Ordinary Shares

Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colonystimulating factor 1 receptor, or CSF1R, and c-KIT inhibitor for the treatment of pulmonary arterial hypertension; GB004, a gut-targeted, oral small molecule for the treatment of inflammatory bowel disease; GB5121, an oral, irreversible, covalent, small molecule inhibitor of Bruton's Tyrosine Kinase for the treatment of primary central nervous system lymphoma; and GB7208, an oral, small molecule, BTK inhibitor for the treatment of multiple sclerosis. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds; and Aerpio Pharmaceuticals, Inc. to develop and commercialize GB004 and related compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. Gossamer Bio, Inc. was incorporated in 2015 and is headquartered in San Diego, California.

Gossamer Bio, Inc.

GoHealth, Inc. operates as a health insurance marketplace and Medicare focused digital health company in the United States. It operates through four segments: Medicare—Internal; Medicare—External; Individual and Family Plans (IFP) and Other—Internal; and IFP and Other—External. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs. Its products include Medicare Advantage, Medicare Supplement, Medicare prescription drug plans, and Medicare Special Needs Plans; and IFP, dental plans, vision plans, and other ancillary plans to individuals. The company sells its products through carriers and online platform, as well as independent and external agencies. GoHealth, Inc. was founded in 2001 and is headquartered in Chicago, Illinois with additional offices in Charlotte, North Carolina, Lindon, Utah, Bratislava, Slovakia, and Kosice, Slovakia.

GoHealth, Inc.

Alight, Inc. operates as a cloud-based provider of integrated digital human capital and business solutions worldwide. It operates through three segments: Employer Solutions, Professional Services, and Hosted Business. The company's solutions enable employees to enrich their health, wealth, and wellbeing, which helps organizations achieve a high-performance culture. It offers employer solutions comprising integrated benefits administration, healthcare navigation, financial health, employee wellbeing, and payroll; and professional services, including cloud deployment and consulting offerings that provides human capital and financial platforms, as well as cloud advisory and deployment, and optimization services for cloud platforms, such as Workday, SAP SuccessFactors, Oracle, and Cornerstone OnDemand. Alight, Inc. was founded in 2017 and is headquartered in Lincolnshire, Illinois.

Alight, Inc.

Nano Labs Ltd operates as a fabless integrated circuit design company and product solution provider in the People's Republic of China and internationally. The company develops high throughput computing and high-performance computing chips. It also offers distributed computing and storage solutions, smart network interface cards, and vision computing chips, as well as distributed rendering technology. In addition, the company engages in the research and development of software. Its customers include enterprises and individual buyers. The company was incorporated in 2019 and is headquartered in Hangzhou, the People's Republic of China.

Nano Labs Ltd

ALT5 Sigma Corporation operates a next generation blockchain platform. It engages in the tokenization, trading, clearing settlement, payment, and safe keeping of digital assets. The company's products include ALT 5 Prime, an electronic over-the-counter trading platform to buy and sell digital assets; and ALT 5 Pay that enables payment processors to accept digital assets as payments, as well as make payment in digital assets. It is also involved in the developing of solutions for opioid crisis. The company was formerly known as JanOne Inc. and changed its name to ALT5 Sigma Corporation in July 2024. ALT5 Sigma Corporation was founded in 1976 and is based in Las Vegas, Nevada.

ALT5 Sigma Corporation

Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as a chemoimmunotherapy combination for metastatic breast cancer. The company also develops TACTI-002, which is in a Phase II clinical trial for the treatment of head and neck squamous cell carcinoma (HNSCC) and non-small cell lung cancer; TACTI-003 that is in Phase IIb clinical trial to treat HNSCC; and INSIGHT-004 and INSIGHT-003, which is in a Phase I clinical trial for the treatment of solid tumors, as well as INSIGHT-005 that is in Phase I/IIa clinical trial to treat solid tumors. Its other products include IMP761, an agonist of lymphocyte activation gene 3 for autoimmune disease; IMP701, an antagonist antibody that acts to stimulate T cell proliferation in cancer patients; and IMP731, a depleting antibody that removes T cells involved in autoimmunity. Immutep Limited has collaboration agreements with GlaxoSmithKline, Novartis, CYTLIMIC Inc., Merck & Co., Inc., Institute of Clinical Cancer Research, Merck KGaA, and EOC Pharma. The company was formerly known as Prima BioMed Ltd and changed its name to Immutep Limited in November 2017. Immutep Limited was incorporated in 1987 and is based in Sydney, Australia.

Immutep Limited

Kelly Services, Inc., together with its subsidiaries, provides workforce solutions to various industries. The company operates through five segments: Professional & Industrial; Science, Engineering & Technology; Education; Outsourcing & Consulting; and International. The Professional & Industrial segment delivers staffing, outcome-based, and direct-hire services in the areas of office, professional, light industrial, and contact center specialties. The Science, Engineering & Technology segment offers staffing, outcome-based, and direct-hire services in the areas of science and clinical research, engineering, information technology, and telecommunications specialties. The Education segment provides staffing and executive search services to early childhood, and higher education markets. The Outsourcing & Consulting segment offers recruitment process outsourcing (RPO), payroll process outsourcing, and talent advisory services, as well as managed services. The International segment provides staffing, RPO, and direct-hire services in Europe and Mexico. The company serves customers in the United States, Canada, Mexico, Puerto Rico, France, Switzerland, Portugal, Russia, the United Kingdom, Italy, Germany, Ireland, rest of Europe, and the Asia-Pacific region. Kelly Services, Inc. was founded in 1946 and is headquartered in Troy, Michigan.

Kelly Services, Inc.

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase III clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase that is in preclinical development for the treatment of fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California.

aTyr Pharma, Inc.

Chaince Digital Holdings Inc., a digital fintech company, provides access to the AI-powered infrastructure, blockchain, and digital assets in the United States. The company offers blockchain and digital asset solutions; and AI and HPC infrastructure, as well as liquid cooling solutions for AI data centers. It also provides broker-dealer, and investment advisory services. The company was formerly known as Mercurity Fintech Holding Inc. and changed its name to Chaince Digital Holdings Inc. in November 2025. Chaince Digital Holdings Inc. was incorporated in 2011 and is headquartered in New York, New York.

Chaince Digital Holdings Inc.

Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the treatment of tumor. The company is also developing Navicixizumab (OMP-305B83), which has completed Phase 1b clinical trials for the treatment of the late line ovarian cancer; Acumapimod (BCT-197), a p38 MAP kinase inhibitor that is in Phase II clinical trials to treat acute exacerbations of chronic obstructive pulmonary disease; and Leflutrozole (BGS-649), an oral aromatase inhibitor for the treatment of hypogonadotropic hypogonadism. In addition, it develops rare disease product candidates, including Setrusumab (BPS-804), a novel antibody for the treatment of osteogenesis imperfecta; and Alvelestat (MPH-966), an oral small molecule that is in Phase II clinical trial to treat Alpha-1 antitrypsin deficiency. The company has a collaboration with The University of Texas MD Anderson Cancer Center to evaluate anti-TIGIT therapeutic antibody candidate, etigilimab. Mereo BioPharma Group plc was incorporated in 2015 and is based in London, the United Kingdom.

Mereo BioPharma Group plc

NextNRG Inc. operates as a mobile fueling company primarily in Florida. It offers on-demand fueling services to consumer, fleet, marine, and other specialty markets. The company was incorporated in 2019 and is based in Miami, Florida.

NextNRG Inc.

Discover stocks hovering near their 52-week lows by comparing current prices to each company's published range. This curated list surfaces potential rebound candidates for value-focused investors who track oversold opportunities across sectors.

#	Company	Industry	Price	Vs 52W High	Market Cap	Analyst Target	P/E	Dividend	DCF	Score	Value	Profit	Growth	Health
1	Quhuo Limited QH NASDAQ CN	Software - Appl…	$0.09 -0.02 (-4.96%)	-99.94% vs $169.11	$10.23 M	-	360.45	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
2	Golden Matrix Group, Inc. GMGI NASDAQ US	Electronic Gami…	$0.64 0.06 (-1.94%)	-99.36% vs $99.36	$8.05 M	$1.80	-1.21	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
3	Lavoro Limited LVRO NASDAQ BR	Agricultural In…	$0.13 0.00 (-14.52%)	-97.20% vs $4.68	$34.95 M	$3.12	-2.48	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
4	T3 Defense Inc. DFNS NASDAQ US	Aerospace & Def…	$0.37 -0.27 (21.17%)	-98.59% vs $26.21	$41.71 M	-	-0.80	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
5	Cresud S.A. Warrant 2021-08.03... CRESW NASDAQ AR	Conglomerates	$0.03 0.00 (1.29%)	-96.10% vs $0.79	$976.39 K	-	5.12	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
6	New Fortress Energy Inc. NFE NASDAQ US	Regulated Gas	$0.63 0.03 (-6.34%)	-87.20% vs $4.96	$181.09 M	$8.52	-0.08	$0.40	-	0 / 100	- / 100	- / 100	- / 100	- / 100
7	Agilon Health, Inc. AGL NYSE US	Medical - Care …	$86.39 5.82 (4.19%)	-4.52% vs $90.48	$1.44 B	$1.32	-0.35	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
8	Tevogen Bio Holdings Inc. TVGN NASDAQ US	Biotechnology	$9.61 -0.44 (11.18%)	-87.27% vs $75.50	$29.46 M	-	-2.09	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
9	Webull Corporation Class A Ord... BULL NASDAQ US	Software - Appl…	$6.18 -0.43 (-12.91%)	-66.27% vs $18.32	$3.29 B	$18.00	-251.59	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
10	Gossamer Bio, Inc. GOSS NASDAQ US	Biotechnology	$0.21 0.01 (1.80%)	-94.57% vs $3.87	$46.73 M	$1.94	-0.43	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
11	GoHealth, Inc. GOCO NASDAQ US	Insurance - Bro…	$0.65 -0.02 (3.94%)	-96.15% vs $17.01	$38.76 M	$7.99	-0.11	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
12	Alight, Inc. ALIT NYSE US	Software - Appl…	$0.82 0.01 (-0.57%)	-86.61% vs $6.11	$430.96 M	$4.63	-0.10	$0.12	-	0 / 100	- / 100	- / 100	- / 100	- / 100
13	Nano Labs Ltd NA NASDAQ CN	Semiconductors	$2.48 -0.05 (-8.90%)	-92.12% vs $31.48	$166.99 M	-	0.00	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
14	ALT5 Sigma Corporation ALTS NASDAQ US	Software - Appl…	$0.85 0.00 (13.68%)	-92.19% vs $10.95	$119.56 M	-	-0.23	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
15	Immutep Limited IMMP NASDAQ AU	Biotechnology	$0.49 0.01 (-4.39%)	-86.24% vs $3.53	$71.61 M	-	-7.27	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
16	Kelly Services, Inc. KELYB NASDAQ US	Staffing & Empl…	$17.58 -0.38 (-2.81%)	-85.94% vs $125.00	$614.42 M	-	-1.16	$0.30	-	0 / 100	- / 100	- / 100	- / 100	- / 100
17	aTyr Pharma, Inc. ATYR NASDAQ US	Biotechnology	$0.49 -0.04 (-2.06%)	-93.28% vs $7.29	$48.05 M	$4.87	-1.09	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
18	Chaince Digital Holdings Inc. CD NASDAQ US	Information Tec…	$7.39 -2.06 (-1.66%)	-79.90% vs $36.77	$587.09 M	-	-54.49	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
19	Mereo BioPharma Group plc MREO NASDAQ GB	Biotechnology	$0.28 -0.00 (0.00%)	-90.88% vs $3.05	$44.42 M	$2.45	-1.48	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100
20	NextNRG Inc. NXXT NASDAQ US	Renewable Utili…	$0.86 0.01 (NaN%)	-75.26% vs $3.48	$46.41 M	$5.00	-0.68	$0.00	-	0 / 100	- / 100	- / 100	- / 100	- / 100

52 Week Low Stocks

Discover stocks hovering near their 52-week lows by comparing current prices to each company's published range. This curated list surfaces potential rebound candidates for value-focused investors who track oversold opportunities across sectors.